MIRO

Miromatrix Medical Inc.

3.40 USD

Last updated Dec 3, 00:32 UTC

Yesterday HIGH

$3.39

Yesterday LOW

$3.37

52w HIGH

$4.35

52w LOW

$0.91

EPS

-0.24

PE

-14.17

Next Earnings

Apr 1, 2024

Overview News Government Trades

Miromatrix Medical Inc. stock is up 1.8% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 December’s closed higher than November.

Miromatrix Medical Inc. develops novel technology for bioengineering fully transplantable organs. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

miromatrix.com

Benzinga Newsdesk

Fri May 12, 2023

Piper Sandler Maintains Overweight on Miromatrix Medical, Lowers Price Target to $3

Piper Sandler analyst Matt O'Brien maintains Miromatrix Medical (NASDAQ:MIRO) with a Overweight and lowers the price target from $6 to $3.
Benzinga Insights

Thu May 11, 2023

Miromatrix Medical: Q1 Earnings Insights
Benzinga Newsdesk

Thu May 11, 2023

Miromatrix Medical Q1 EPS $(0.33) Misses $(0.29) Estimate

Miromatrix Medical (NASDAQ:MIRO) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.29) by 13.79 percent. This is a 5.71 percent increase over losses of $(0.35) per share
Benzinga Insights

Thu May 11, 2023

Earnings Scheduled For May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
Benzinga Insights

Thu May 4, 2023

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 498 companies reached new 52-week lows.
Benzinga Insights

Thu Apr 13, 2023

Stocks That Hit 52-Week Lows On Thursday

During Thursday's trading, 110 companies set new 52-week lows.
Benzinga Newsdesk

Wed Apr 5, 2023

CareDx And Miromatrix Medical Have Announced An Exclusive Partnership To Advance Research Using Bioengineered Organs For Human Transplantation, Terms Not Disclosed

CareDx will develop an innovative testing solution for Miromatrix to use in pre-clinical animal models and will be the exclusive provider of donor-derived cell-free DNA (dd-cfDNA) testing services for use in human
Benzinga Newsdesk

Mon Apr 3, 2023

Piper Sandler Maintains Overweight on Miromatrix Medical, Lowers Price Target to $6

Piper Sandler analyst Matt O'Brien maintains Miromatrix Medical (NASDAQ:MIRO) with a Overweight and lowers the price target from $9 to $6.
Benzinga Newsdesk

Fri Mar 31, 2023

Miromatrix Medical Q4 EPS $(0.33) Beats $(0.39) Estimate

Miromatrix Medical (NASDAQ:MIRO) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 22.22 percent decrease over losses of $(0.27) per share
Benzinga Insights

Fri Mar 31, 2023

Earnings Scheduled For March 31, 2023

Companies Reporting Before The Bell • Pioneer Muni High Inc (NYSE:MAV) is likely to report quarterly earnings at $0.05 per share on revenue of $35.00 million.